Inovio Biomedical Corporation Develops Cordless Electroporation Device for Delivering DNA Vaccines

Published: Mar 03, 2010

SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, has unveiled its new CELLECTRA®-SP series of hand-held, cordless electroporation devices at the DNA Vaccines 2010 conference being held in New Orleans, LA.

Back to news